{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:56:17Z","timestamp":1793228177011,"version":"4.5.0"},"reference-count":73,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaleida Troup"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Mucositis involving the gastrointestinal, vaginal, and nasal mucosa is one of the primary dose-limiting toxicities of hematopoietic stem cell transplantation (HSCT) and its conditioning regimen. The oropharyngeal mucosa is commonly affected, which can be detrimental to patient health and quality of life. Despite its significant prevalence and deleterious effects, we have an inadequate understanding of the risk factors and outcomes associated with oral mucositis (OM). We performed a literature search through PubMed and EBSCO (inception to 31 March 2024) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data was extracted from eligible studies using a pre-specified data extraction form. Quality of the data was assessed using the Newcastle-Ottawa Scale for non-randomized, observational studies and the Cochrane Collaboration Tool for randomized controlled trials. Our initial search identified 1677 articles, 34 of which were included in our study. Of those 34, 30 were included in the qualitative assessment of clinical risk factors in the development of OM, and 4 were included in the meta-analysis assessing the relationship between OM and infectious complications following HSCT. Across both HSCT modalities and cancer cohorts, female sex and high-intensity conditioning were common risk factors in the development of OM. When stratified by allogeneic and autologous HSCT, methotrexate, younger age, and longer duration of neutropenia were associated with increased OM risk in allogeneic HSCT recipients, while renal dysfunction, HSV-1 reactivation, and longer neutrophil engraftment were associated with increased OM risk in autologous HSCT recipients. Longer neutrophil engraftment was a common risk factor across different cancer cohorts; however, renal dysfunction was a distinct risk factor for OM in multiple myeloma patients. Additionally, our meta-analysis revealed that patients with OM have an increased risk of developing infectious complications following HSCT compared to those without OM, with an odds ratio of 3.84 (95% CI: 2.51\u20135.86). The development of OM is related to various risk factors, and individuals with OM are at greater risk of infectious complications. Knowledge of these risk factors and outcomes will help clinicians identify high-risk individuals, prevent OM, and protect an immunocompromised population from subsequent life-threatening complications.<\/jats:p>","DOI":"10.3390\/cancers17162657","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:16:37Z","timestamp":1755184597000},"page":"2657","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Elevated Likelihood of Infectious Complications Related to Oral Mucositis After Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Outcomes and Risk Factors"],"prefix":"10.3390","volume":"17","author":[{"given":"Susan","family":"Eichhorn","sequence":"first","affiliation":[{"name":"Boston Medical Center, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2505-3014","authenticated-orcid":false,"given":"Lauryn","family":"Rudin","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidambaram","family":"Ramasamy","sequence":"additional","affiliation":[{"name":"Carol and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT 06030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0274-7257","authenticated-orcid":false,"given":"Ridham","family":"Varsani","sequence":"additional","affiliation":[{"name":"School of Dental Medicine, University at Buffalo, Buffalo, NY 14215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-1595","authenticated-orcid":false,"given":"Parikshit","family":"Padhi","sequence":"additional","affiliation":[{"name":"Kaleida Health Infusion Center, Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY 14221, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Nassour","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Meleveedu","sequence":"additional","affiliation":[{"name":"Carol and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT 06030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[{"name":"City of Hope National Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Semegran","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-6627","authenticated-orcid":false,"given":"Poolakkad S.","family":"Satheeshkumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cden.2013.12.005","article-title":"Chemotherapy or radiation-induced oral mucositis","volume":"58","author":"Lalla","year":"2014","journal-title":"Dent. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"eRW4007","DOI":"10.1590\/s1679-45082018rw4007","article-title":"Chemotherapy protocols and incidence of oral mucositis. An integrative review","volume":"16","author":"Curra","year":"2018","journal-title":"Einstein (Sao Paulo)"},{"key":"ref_3","first-page":"199","article-title":"Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma","volume":"31","author":"Satheeshkumar","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_4","unstructured":"Khaddour, K., Hana, C.K., and Mewawalla, P. (2025, July 23). Hematopoietic Stem Cell Transplantation, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/30725636\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/S2352-3026(21)00231-3","article-title":"Haematopoietic Stem-Cell Transplantation in Older Adults: Geriatric Assessment, Donor Considerations, and Optimization of Care","volume":"8","author":"Kennedy","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5152\/FNJN.2024.23049","article-title":"Evaluation of the Incidence and Stage of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study","volume":"32","author":"Kara","year":"2024","journal-title":"Florence Nightingale J. Nurs."},{"key":"ref_8","unstructured":"World Health Organization (1979). WHO Handbook for Reporting Results of Cancer Treatment."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","article-title":"Oral mucositis: The hidden side of cancer therapy","volume":"39","author":"Pulito","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2015045","DOI":"10.4084\/mjhid.2015.045","article-title":"Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients","volume":"7","author":"Balletto","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269.e1","DOI":"10.1016\/j.jtct.2025.02.010","article-title":"Bloodstream Infections and Colonization in Hematopoietic Stem Cell Transplant Recipients at a South African Center: A Retrospective Analysis","volume":"31","author":"McMillan","year":"2025","journal-title":"Transplant. Cell Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5603\/AHP.a2022.0015","article-title":"Assessment of Colonization and Infection Epidemiology in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single-Center Study","volume":"53","author":"Krawiec","year":"2022","journal-title":"Acta Haematol. Pol."},{"key":"ref_15","first-page":"70","article-title":"Incidence and Risk Factors for Radiotherapy-Induced Oral Mucositis Among Patients With Nasopharyngeal Carcinoma: A Meta-Analysis","volume":"17","author":"Li","year":"2023","journal-title":"Asian Nurs. Res. (Korean Soc. Nurs. Sci.)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.6061\/clinics\/2013(06)11","article-title":"Oral health as a predictive factor for oral mucositis","volume":"68","author":"Coracin","year":"2013","journal-title":"Clinics"},{"key":"ref_17","first-page":"5059","article-title":"Prediction of mucositis risk secondary to cancer therapy: A systematic review of current evidence and call to action","volume":"28","author":"Wardill","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_18","first-page":"841","article-title":"GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis","volume":"23","author":"Coleman","year":"2015","journal-title":"Support. Care Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbmt.2015.09.014","article-title":"The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review","volume":"22","author":"Chaudhry","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_20","first-page":"100252","article-title":"Race\/ethnicity reporting and representation in US clinical trials: A cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s13063-022-07004-2","article-title":"Underrepresentation of women in randomized controlled trials: A systematic review and meta-analysis","volume":"23","author":"Daitch","year":"2022","journal-title":"Trials"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chiang, T.C., Huang, M.S., Lu, P.L., Huang, S.T., and Lin, Y.C. (2020). The effect of oral care intervention on pneumonia hospitalization, Staphylococcus aureus distribution, and salivary bacterial concentration in Taiwan nursing home residents: A pilot study. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05061-z"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_24","unstructured":"Wells, G., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2021, June 20). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2003-05-1425","article-title":"The natural history of respiratory syncytial virus infection in cancer and transplant patients: Implications for management","volume":"103","author":"Anaissie","year":"2004","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e30104","DOI":"10.1097\/MD.0000000000030104","article-title":"Investigation of typhlitis in bone marrow transplant patients in a stem cell transplant unit","volume":"101","author":"Deveci","year":"2022","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12648","DOI":"10.1111\/tid.12648","article-title":"Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Qu\u00e9bec, Canada","volume":"19","author":"Talbot","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3062.2010.00544.x","article-title":"Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients","volume":"12","author":"Mikulska","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S1516-31802012000100003","article-title":"Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution","volume":"130","author":"Santos","year":"2012","journal-title":"Sao Paulo Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00277-007-0266-x","article-title":"Early clinical impact of iron overload in stem cell transplantation. A prospective study","volume":"86","author":"Altes","year":"2007","journal-title":"Ann. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/ejh.12386","article-title":"Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma","volume":"93","author":"Batlle","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","article-title":"Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy\u2014European Blood and Marrow Transplantation Mucositis Advisory Group","volume":"26","author":"Blijlevens","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cpt.644","article-title":"Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial","volume":"102","author":"Cho","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5045\/br.2019.54.1.23","article-title":"Efficacy of parenteral glutamine supplementation in adult hematopoietic stem cell transplantation patients","volume":"54","author":"Cho","year":"2019","journal-title":"Blood Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gebri, E., Kiss, A., T\u00f3th, F., and Hortob\u00e1gyi, T. (2020). Female sex as an independent prognostic factor in the development of oral mucositis during autologous peripheral stem cell transplantation. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-72592-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bmt.1705590","article-title":"Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: A prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group","volume":"39","author":"Gori","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bmt.1705471","article-title":"Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: Incidence, risk factors and a severity predictive model","volume":"38","author":"Grazziutti","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3904\/kjim.2018.469","article-title":"Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies","volume":"35","author":"Hong","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"ref_40","first-page":"933","article-title":"A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens","volume":"20","author":"Kashiwazaki","year":"2012","journal-title":"Support. Care Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/tid.12118","article-title":"Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kawamura","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"ref_42","first-page":"3231","article-title":"Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients","volume":"20","author":"Laheij","year":"2012","journal-title":"Support. Care Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lee, S.E., Lim, J.Y., Ryu, D.B., Kim, T.W., Jeon, Y.W., Yoon, J.H., Cho, B.S., Eom, K.S., Kim, Y.J., and Kim, H.J. (2018). Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/5097325"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lee, A., Hong, J., Shin, D.Y., Koh, Y., Yoon, S.S., Kim, P.J., Kim, H.G., Kim, I., Park, H.K., and Choi, Y. (2020). Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041090"},{"key":"ref_45","first-page":"1749","article-title":"The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients","volume":"23","author":"Legert","year":"2015","journal-title":"Support. Care Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/odi.13663","article-title":"Oral mucositis after tacrolimus\/sirolimus or cyclosporine\/methotrexate as graft-versus-host disease prophylaxis","volume":"27","author":"Remberger","year":"2021","journal-title":"Oral Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bcp.12906","article-title":"High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation","volume":"82","author":"Nath","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_48","first-page":"3141","article-title":"Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: A single-institution retrospective evaluation","volume":"23","author":"Nguyen","year":"2015","journal-title":"Support. Care Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/leu.2008.323","article-title":"Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia","volume":"23","author":"Rocha","year":"2009","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5737\/1181912x1512931","article-title":"Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation","volume":"15","author":"Salvador","year":"2005","journal-title":"Can. Oncol. Nurs. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ejh.13299","article-title":"Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Shouval","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bmt.2011.53","article-title":"Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD","volume":"47","author":"Sugita","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_53","first-page":"142","article-title":"Factors Affecting the Incidence and Severity of Oral Mucositis Following Hematopoietic Stem Cell Transplantation","volume":"12","author":"Valeh","year":"2018","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/j.clnu.2023.10.018","article-title":"The impact of malnutrition on mortality and complications of hematopoietic stem cell transplantation in patients with acute leukemia","volume":"42","author":"Barkhordar","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.14740\/jh1148","article-title":"The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning","volume":"12","author":"Ursu","year":"2023","journal-title":"J. Hematol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.transproceed.2024.01.056","article-title":"Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients","volume":"56","author":"Yegin","year":"2024","journal-title":"Transplant. Proc."},{"key":"ref_57","first-page":"494","article-title":"Prospective longitudinal analysis of clinical and immunological risk factors associated with oral and gastrointestinal mucositis following autologous stem cell transplant in adults","volume":"31","author":"Wong","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.oraloncology.2015.09.008","article-title":"Enhanced Oral Healing Following Local Mesenchymal Stromal Cell Therapy","volume":"51","author":"Tour","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_59","first-page":"521","article-title":"Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning","volume":"31","author":"Oku","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.jtct.2022.10.003","article-title":"Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge","volume":"29","author":"Lachance","year":"2023","journal-title":"Transplant. Cell Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1918668","DOI":"10.1001\/jamanetworkopen.2019.18668","article-title":"Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant","volume":"3","author":"Dandoy","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00784-021-04106-0","article-title":"Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients","volume":"26","author":"Satheeshkumar","year":"2022","journal-title":"Clin. Oral Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e13102","DOI":"10.1111\/ijn.13102","article-title":"The effect of cryotherapy on oral mucositis management in patients undergoing stem cell transplantation: A systematic review of randomized controlled trials","volume":"29","author":"Sezgin","year":"2023","journal-title":"Int. J. Nurs. Pract."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/asheducation-2018.1.228","article-title":"Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation","volume":"2018","author":"Hamilton","year":"2018","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/ijmpo.ijmpo_113_18","article-title":"Methotrexate and Mucositis: A Merry-Go-Round for Oncologists","volume":"40","author":"Mishra","year":"2019","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ejh.13101","article-title":"Autologous peripheral blood stem cell transplantation in dialysis-dependent multiple myeloma patients-DAUTOS Study of the Polish Myeloma Study Group","volume":"101","author":"Lewandowski","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/jnci\/94.24.1883","article-title":"Role of body surface area in dosing of investigational anticancer agents in adults, 1991\u20132001","volume":"94","author":"Baker","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41409-022-01657-y","article-title":"Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: A safe and effective option","volume":"57","author":"Lazana","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/nu7095388","article-title":"Magnesium in Prevention and Therapy","volume":"7","author":"Schmidt","year":"2015","journal-title":"Nutrients"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ndt\/gfm571","article-title":"Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation","volume":"23","author":"Philibert","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100152","DOI":"10.1016\/j.crphar.2022.100152","article-title":"Sex differences in drug effects and\/or toxicity in oncology","volume":"4","author":"Rakshith","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2009.12.015","article-title":"Sex steroids as inflammatory regulators","volume":"120","author":"Gilliver","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2657\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:44Z","timestamp":1760034464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":73,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["cancers17162657"],"URL":"https:\/\/doi.org\/10.3390\/cancers17162657","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}